Metal organic framework, (MOFs) supported nanoparticles have proven a path for the treatment of various carcinomas to be effective against MCF-7 Breast cancer cell lines. Despite the globally widespread applications of nickel/nickel oxide nanoparticles, Ni/NiO@LAA_PEG NPs with surfactant Polyethylene glycol, (PEG) and l-Acsorbic acid, (LAA) as reducing agents in industrial, commercial, and biomedical fields, their response to human cells has not been elucidated. Hence in the reported article Ni/NiO@LAA_PEG NPs with an average size range of 75–80 nm was used to study their interaction with MCF-7 Breast cancer cell lines. So the best of our understanding this is the study related to MCF-7 Human Breast cancer cell lines to show cyto-genotoxicity of Ni/NiO@LAA_PEG NPs which seems mediated through MTT analysis with rising effect surface enhancement and indexed porosiveness for the interfacial advancement than standard drug Doxorubicin for their comparison to show their best effectivity to prepared Ni/NiO@LAA_PEG NPs.The theoretical performance was simulated using Gaussian-09@Autodock 4.2 with crystal preparation and docked with MCF-7 Human Breast cancer cell lines PDBs to show their correlation with wet method of preparation. The synthesized Ni/NiO@LAA_PEG NPs was characterized against UV/Vis spectroscopy for determination of peak pattern of 395 nm, the functional group analysis for the best binding of stretching with framed metal network of nanoparticles was to shown out their scissoring, wagging, and CH stretching, etc. at 661, 834 and 3425 cm−1respectively by FTIR analysis and an energy band gap of 2.2 eV for Ni/NiO@LAA_PEG NPs by optical studies. The mesopore range and surface area measurement was calculated with BET adsorption and BJH plot to find their coercivity and retentivity via adsorption-desorption curve for their best catalytic performance. The current interpretation of Ni 2p spectra of oxides and other compounds is based on charge transfer assignment of the main peak at 856.4 eV and broad satellite cantered at about 861 eV to the cd9 L and unscreened cd8 final state configurations.
Read full abstract